Literature DB >> 11764262

Utilizing propensity scores to estimate causal treatment effects with censored time-lagged data.

K J Anstrom1, A A Tsiatis.   

Abstract

Observational studies frequently are conducted to compare long-term effects of treatments. Without randomization, patients receiving one treatment are not guaranteed to be prognostically comparable to those receiving another treatment. Furthermore, the response of interest may be right-censored because of incomplete follow-up. Statistical methods that do not account for censoring and confounding may lead to biased estimates. This article presents a method for estimating treatment effects in nonrandomized studies with right-censored responses. We review the assumptions required to estimate average causal effects and derive an estimator for comparing two treatments by applying inverse weights to the complete cases. The weights are determined according to the estimated probability of receiving treatment conditional on covariates and the estimated treatment-specific censoring distribution. By utilizing martingale representations, the estimator is shown to be asymptotically normal and an estimator for the asymptotic variance is derived. Simulation results are presented to evaluate the properties of the estimator. These methods are applied to an observational data set of acute coronary syndrome patients from Duke University Medical Center to estimate the effect of a treatment strategy on the mean 5-year medical cost.

Entities:  

Mesh:

Year:  2001        PMID: 11764262     DOI: 10.1111/j.0006-341x.2001.01207.x

Source DB:  PubMed          Journal:  Biometrics        ISSN: 0006-341X            Impact factor:   2.571


  9 in total

1.  Semiparametric estimation of treatment effect with time-lagged response in the presence of informative censoring.

Authors:  Xiaomin Lu; Anastasios A Tsiatis
Journal:  Lifetime Data Anal       Date:  2011-06-26       Impact factor: 1.588

2.  Relationship between anemia and health care costs in heart failure.

Authors:  Larry A Allen; Kevin J Anstrom; John R Horton; Linda K Shaw; Eric L Eisenstein; G Michael Felker
Journal:  J Card Fail       Date:  2009-12       Impact factor: 5.712

3.  Assessing the economic attractiveness of coronary artery revascularization in chronic kidney disease patients.

Authors:  Eric L Eisenstein; Jie L Sun; Kevin J Anstrom; Elizabeth R DeLong; Lynda A Szczech; Daniel B Mark
Journal:  J Med Syst       Date:  2009-08       Impact factor: 4.460

4.  Clinical effectiveness of coronary stents in elderly persons: results from 262,700 Medicare patients in the American College of Cardiology-National Cardiovascular Data Registry.

Authors:  Pamela S Douglas; J Matthew Brennan; Kevin J Anstrom; Art Sedrakyan; Eric L Eisenstein; Ghazala Haque; David Dai; David F Kong; Bradley Hammill; Lesley Curtis; David Matchar; Ralph Brindis; Eric D Peterson
Journal:  J Am Coll Cardiol       Date:  2009-05-05       Impact factor: 24.094

5.  Estimating propensity scores and causal survival functions using prevalent survival data.

Authors:  Yu-Jen Cheng; Mei-Cheng Wang
Journal:  Biometrics       Date:  2012-07-26       Impact factor: 2.571

6.  Clinical effectiveness of beta-blockers in heart failure: findings from the OPTIMIZE-HF (Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure) Registry.

Authors:  Adrian F Hernandez; Bradley G Hammill; Christopher M O'Connor; Kevin A Schulman; Lesley H Curtis; Gregg C Fonarow
Journal:  J Am Coll Cardiol       Date:  2009-01-13       Impact factor: 24.094

7.  Estimating treatment effects on the marginal recurrent event mean in the presence of a terminating event.

Authors:  Douglas E Schaubel; Min Zhang
Journal:  Lifetime Data Anal       Date:  2010-01-10       Impact factor: 1.588

8.  Outcomes of second revascularization procedures after stent implantation.

Authors:  Richard P Konstance; Eric L Eisenstein; Kevin J Anstrom; Linda K Shaw; Robert M Califf; Robert A Harrington; David B Matchar; Kevin A Schulman; David F Kong
Journal:  J Med Syst       Date:  2008-04       Impact factor: 4.460

9.  Propensity score and doubly robust methods for estimating the effect of treatment on censored cost.

Authors:  Jiaqi Li; Elizabeth Handorf; Justin Bekelman; Nandita Mitra
Journal:  Stat Med       Date:  2015-12-17       Impact factor: 2.373

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.